Scotland · NHS Scotland MSAN
Oral Contraceptive tablets (various brands)
MSAN(2021)14 · Level 2 · issued 31 Mar 2021
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| microgram / Cyproterone composition remain available from suppliers of the | Available | — |
| Femodette w/c 03 May 2021 remain available from suppliers of the following | Available | — |
| Drospirenone remain available from suppliers of the following | Available | — |
| professionals on the use of combined hormonal contraceptives is available from the Faculty of | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2021:14
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
1cad85974d9a12a835d54199efea1efd9e380665649b387f03cf84b313fe1e3fsha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2021-14.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.